Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maj-Britt Jensen

Showing results (1-10 of 152) with videos related to

Pageof 16
Sort By:
Journal of the National Cancer Institute|May 22, 2023
Response to Van Cauwenberge, Borremans, Van Houdt, et alSøren Cold, Maj-Britt Jensen, Bent Ejlertsen
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89Bent Ejlertsen, Henning T Mouridsen, Maj-Britt Jensen
Acta Oncologica (Stockholm, Sweden)|November 14, 2013
Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancerBent Ejlertsen, Maj-Britt Jensen, Henning T Mouridsen, et al.
Clinical Epidemiology|November 9, 2016
Danish Breast Cancer Cooperative GroupPeer Christiansen, Bent Ejlertsen, Maj-Britt Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative GroupNiels Kroman, Maj-Britt Jensen, Jan Wohlfahrt, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2007
Invasive lobular breast cancer. Prognostic significance of histological malignancy gradingMaj-Lis Møller Talman, Maj-Britt Jensen, Fritz Rank
Breast Cancer Research and Treatment|August 19, 2011
Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancerTove F Tvedskov, Maj-Britt Jensen, Niels Kroman, et al.
Acta Oncologica (Stockholm, Sweden)|June 19, 2013
Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel nodeTove F Tvedskov, Maj-Britt Jensen, Eva Balslev, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised studyHelge Johansen, Sigvard Kaae, Maj-Britt Jensen, et al.
Danish Medical Journal|January 3, 2025
Compliance with endocrine therapy among breast cancer survivorsEmma Marie Torpe, Tobias Berg, Maj-Britt Jensen, et al.
Pageof 16

Showing results (1-10 of 152) with videos related to

Sort By:
Pageof 16
Journal of the National Cancer Institute|May 22, 2023
Response to Van Cauwenberge, Borremans, Van Houdt, et alSøren Cold, Maj-Britt Jensen, Bent Ejlertsen
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89Bent Ejlertsen, Henning T Mouridsen, Maj-Britt Jensen
Acta Oncologica (Stockholm, Sweden)|November 14, 2013
Excess mortality in postmenopausal high-risk women who only receive adjuvant endocrine therapy for estrogen receptor positive breast cancerBent Ejlertsen, Maj-Britt Jensen, Henning T Mouridsen, et al.
Clinical Epidemiology|November 9, 2016
Danish Breast Cancer Cooperative GroupPeer Christiansen, Bent Ejlertsen, Maj-Britt Jensen, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Pregnancy after treatment of breast cancer--a population-based study on behalf of Danish Breast Cancer Cooperative GroupNiels Kroman, Maj-Britt Jensen, Jan Wohlfahrt, et al.
Acta Oncologica (Stockholm, Sweden)|July 27, 2007
Invasive lobular breast cancer. Prognostic significance of histological malignancy gradingMaj-Lis Møller Talman, Maj-Britt Jensen, Fritz Rank
Breast Cancer Research and Treatment|August 19, 2011
Iatrogenic displacement of tumor cells to the sentinel node after surgical excision in primary breast cancerTove F Tvedskov, Maj-Britt Jensen, Niels Kroman, et al.
Acta Oncologica (Stockholm, Sweden)|June 19, 2013
Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel nodeTove F Tvedskov, Maj-Britt Jensen, Eva Balslev, et al.
Acta Oncologica (Stockholm, Sweden)|May 10, 2008
Extended radical mastectomy versus simple mastectomy followed by radiotherapy in primary breast cancer. A fifty-year follow-up to the Copenhagen Breast Cancer randomised studyHelge Johansen, Sigvard Kaae, Maj-Britt Jensen, et al.
Danish Medical Journal|January 3, 2025
Compliance with endocrine therapy among breast cancer survivorsEmma Marie Torpe, Tobias Berg, Maj-Britt Jensen, et al.
Pageof 16